-
Thomas S. Scanlan, PhD
… at developing agents that penetrate the central nervous system for neurodegenerative diseases including multiple sclerosis, Alzheimer’s, and Parkinson’s disease. …
-
Ganesh Iyer, PhD
… into life-changing treatments. Dr. Iyer has advanced multiple targets from assay development through … for assays supporting targets in the central nervous system and cancer. He holds a PhD in biochemistry from …
-
Sjors Hendrik Willem Scheres, PhD
… of tau, α-synuclein, amyloid-b and TMEM-106B filaments from multiple diseases, revealing that specific folds … Recently, they have started the exploration of model systems that replicate the disease-specific structures. …
-
Parkin Modulates Neuroinflammation to Sustain Dopaminergic Neuronal Health
… of many other cell proteins. Recent studies show that multiple proteins regulating immune function are modified by … dish to evaluate whether the replacement of the immune system that is not functioning in the parkin-depleted cells … findings could lead to approaches to modify the immune system as a way to either prevent PD or to slow its …
-
PPMI Dispatch: Study Leaders Meet to Chart the Future of Parkinson’s Research
May 30, 2023
… in the study with Parkinson’s may have a related disease (multiple system atrophy) instead. These learnings can help engage more …
-
A Skin Test for Parkinson’s? What You Need to Know
March 22, 2024
… conditions, like Dementia with Lewy Bodies (DLB) and multiple system atrophy (MSA). These results are similar to the Synuclein …